{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT06987695","recordId":"NCT06987695","peptideSlug":"maridebart-cafraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06987695-maridebart-cafraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct06987695.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct06987695.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2025-05-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-05-15","publishedAt":"2026-08-23","recordId":"NCT06987695","recordSha256":"fdd4baf96a2b8461e8923e892187435c231eaa3a49dda9b8a55cf3ae17b94ddb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06987695?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2025-06-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-06-24","publishedAt":"2026-08-23","recordId":"NCT06987695","recordSha256":"9cd15a5865cc629ee67b01273b406c6ae39567be1dc089c3ca8b29d9d1f88e5c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06987695?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2025-07-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-07-16","publishedAt":"2026-08-23","recordId":"NCT06987695","recordSha256":"dd5bd62d8711cd3e1684ae882690f4901763d3ee3e6bbdd1d39b4756196f44cf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06987695?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2025-07-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-07-30","publishedAt":"2026-08-23","recordId":"NCT06987695","recordSha256":"0acb79ba726dd6c041dbb250c0afaea2d6a33cf2fb8db1ac2c29e6448d66ad31","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06987695?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2025-08-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-08-06","publishedAt":"2026-08-23","recordId":"NCT06987695","recordSha256":"fdb33c501630c80468ad359ef69d394d53033ec86dd380502ada13ee248cede0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06987695?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Identification","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2025-11-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-11-03","publishedAt":"2026-08-23","recordId":"NCT06987695","recordSha256":"879f9a794da69fdb97a37e51ca9e30e92be312ccb3dbede7f834f1734fd4ac47","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06987695?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2025-12-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-12-15","publishedAt":"2026-08-23","recordId":"NCT06987695","recordSha256":"5eb5df8a30346abc51fe20dd9a7788a801ac71622aec2c2f4b531a416586fe7e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06987695?a=7&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"1c7bc4c577adee3a3f9a7c7cf1155a23e2d09ddec13d33df3c3b55c2fd9f6748"}}